Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2023 Earnings Call Transcript

Operator: Hello. Welcome to Vir Biotechnology Second Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Related Keywords

Paul Choi ,Phil Tang ,Sasha Damouni Ellis ,Damouni Ellis ,Gena Wang ,Goldman Sachs ,Barclays ,Vir Biotechnology Inc ,World Health Organization ,Pfizer ,Nasdaq ,Semiconductor Stocks To ,Corporate Affairs Officer ,Exchange Commission ,Vir Biotechnology ,Call Transcript August ,Vir Biotechnology Second Quarter ,Business Update ,Executive Vice President ,Chief Corporate Affairs ,Marianne De Backer ,Chief Executive Officer ,Phil Pang ,Chief Medical Officer ,Sung Lee ,Chief Financial ,March Phase ,Chief Financial Officer ,Favor Stocks That Hedge Funds Love ,Semiconductor Stocks To Buy For The ,